INCELL
Innovative Life Science Solutions™
Menu
  • Home
    • Contact
    • Close
  • Products
    • My Account
    • Close
  • Reg Med
    • Registrations Licenses & Certifications
    • Cell & Tissue Products
      • Regenerative & Stem Cells
      • Tissue-Derived Products
      • Reagents & Testing
      • INCELL Established Cell Lines
    • Tissue Collections & Kit Products
    • Storage of Cell & Tissue Products
    • Services: Manufacturing , Testing and R&D
      • Accelerated Product Development Services
      • Regenerative & Stem Cell Products
    • Close
  • Micro
    • Microbiology & Vaccine Products
      • Microbiology Testing
        • Sterility: GMP and USP Compliant
        • Microbial Bioburden
        • Endotoxin/Pyrogen Testing
        • Mycoplasma Testing
        • Antimicrobial & Microbiological Testing
        • Antimicrobials: New Product Testing In Vivo
    • Vaccines and Microbiology Products
      • Innovative Platforms, Tools and Vaccines
      • Microbiology & Vaccines Collaborations
    • Clinical Studies
    • Close
  • Clinical
    • Clinical Trials
    • Personalized Medicine
    • Close
  • About
    • Corporate
      • History
      • Mission
      • Registration, Licenses & Certificates
      • Memberships, Boards and Committees
    • Organization & Management
      • Board Members
        • Executive Managers
      • Key Alliances
        • Collaborative Business Model
    • Business Units & Activities
      • Regenerative Medicine
      • Media, Solutions & Kits
      • Microbiology & Vaccine Products
      • 503B Compounding & Formulation
    • Close
  • News
    • Close

Antimicrobials: New Product Testing In Vivo

INCELL is registered and in compliance with USDA animal welfare, research and testing. Facilities, staff, equipment and procedures have been approved for use by the Office of Laboratory Animal Welfare (OLAW) at the National Institutes of Health (NIH). This allows INCELL to perform grant-related work and provide contract services for NIH and other government grants and contracts.

Studies are custom-designed for the client. They can be performed as research studies or be done in compliance with Good Laboratory Practice (GLP). Typical analyses to test biologics, drugs or devices may include:

  • Time course body weights
  • Metabolic measurements
  • Persistent of cells at injection site, organ localization or dissemination
  • Assessment of microbial burden by DNA biochemical or culture analyses
  • Immunoassays of host cells, sera or plasma
  • Necropsy and/or histopathology to assess local responses and microscopic evidence of infection
  • Imaging of slides with statistical and quantitative or qualitative outcomes of test treatment groups compared to appropriate controls
  • Examples of other available analyses include: hematology, clinical chemistry, drug, cytometry, and ultrastructural imaging analyses

RatLookingUp-InvivotestingAnimalCagesDPC58966722

Follow Us

Recent Posts

  • Dr. Mary Pat Moyer inducted to the National Academy of Engineering for her contribution to regenerative medicine, October 2019
  • Dr. Moyer Addresses Orthopedic Physicians at AAOM National Meeting
  • INCELL Global Expansion
  • INCELL Sponsors WSCS in December 2016
  • Dr. Mary Pat Moyer: Luminary Woman of San Antonio

Contact INCELL Corporation LLC

12734 Cimarron Path (Directions)
San Antonio, Texas 78249
Tel: 210-877-0100|Toll-free: 800.364.1765
Fax: 210-877-0200

Privacy | Contact

Copyright © 2021. All Rights Reserved.

Designed by WebAuthorings.